Danas Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer with a broad branded-generics portfolio and local manufacturing operations.
Danas Pharmaceuticals products in Pakistan
Danas Pharmaceuticals (Pvt) Ltd has 87 medicine presentations registered in Pakistan under 46 brands, covering 44 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Danpro (Ciprofloxacin), Devenda (Levetiracetam), Dansetron (Ondansetron) and Autist (Risperidone). 87 products have an official DRAP price on MedInfoBase. See all 46 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Danas Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 312, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
- Website
- danaspharmaceuticals.com ↗
- Phone
- +92 51 4491574
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Danas Pharmaceuticals (Pvt) Ltd. is priced against the market
81 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Aquadan | Water for Injection | 5 mL | Injection | 5ml x 100's | 091944 | PKR 1,039.09 | PKR 2.08/mL | 🔒 Pharma Pro |
| Aquadan 10ml | Water for Injection | 10 mL | Injection | 10ml x 100's | 091943 | PKR 1,607.55 | PKR 1.61/mL | 🔒 Pharma Pro |
| Arex | Cetirizine | 10 mg | Tablet | 1 x 10’s | 038673 | PKR 65.75 | PKR 6.58/tablet | 🔒 Pharma Pro |
| Artedan | Artemether + Lumefantrine | 20 mg + 120 mg | Capsule | 16’s | 038696 | PKR 621.28 | PKR 38.83/capsule | 🔒 Pharma Pro |
| Autist | Risperidone | 4 mg | Tablet | 10’s | 091928 | PKR 757.18 | PKR 75.72/tablet | 🔒 Pharma Pro |
| Autist | Risperidone | 3 mg | Tablet | 10’s | 091929 | PKR 582.44 | PKR 58.24/tablet | 🔒 Pharma Pro |
| Autist | Risperidone | 2 mg | Tablet | 10’s | 091930 | PKR 378.60 | PKR 37.86/tablet | 🔒 Pharma Pro |
| Autist | Risperidone | 1 mg | Tablet | 10’s | 091931 | PKR 232.98 | PKR 23.30/tablet | 🔒 Pharma Pro |
| B-Vir | Entecavir | 0.5 mg | Tablet | 3 x 10’s | 066242 | PKR 18,641.91 | PKR 621.40/tablet | 🔒 Pharma Pro |
| Burnhel | Silver sulfadiazine | 1 % | Cream | 50g | 038715 | PKR 178.62 | PKR 3.57/g | 🔒 Pharma Pro |
| Carbil | Carbimazole | 5 mg | Tablet | 10 x 10’s | 038674 | PKR 84.42 | PKR 0.84/tablet | 🔒 Pharma Pro |
| Danabid | Terbinafine | 1 % | Cream | 10g | 083674 | PKR 294.42 | PKR 29.44/g | 🔒 Pharma Pro |
| Danadex | Dexamethasone | 4 mg | Injection | 1ml x 25's | 072346 | PKR 565.12 | PKR 22.60/mL | 🔒 Pharma Pro |
| Danidol | Paracetamol | 500 mg | Tablet | 20 x 10’s | 091941 | PKR 742.12 | PKR 3.71/tablet | 🔒 Pharma Pro |
| Danim | Tranexamic acid | 500 mg | Injection | 5ml x 10’s | 072348 | PKR 658.83 | PKR 13.18/mL | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 250 mg | Tablet | 1x25 | 038675 | PKR 477.21 | PKR 19.09/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 250 mg | Tablet | 10’s | 038675 | PKR 252.41 | PKR 25.24/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 250 mg | Tablet | 10x10 | 038675 | PKR 1,869.92 | PKR 18.70/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 250 mg | Tablet | 10x5 | 038675 | PKR 934.96 | PKR 18.70/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 500 mg | Tablet | 1x25 | 038676 | PKR 954.40 | PKR 38.18/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 500 mg | Tablet | 10’s | 038676 | PKR 504.79 | PKR 50.48/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 500 mg | Tablet | 10x10 | 038676 | PKR 3,739.73 | PKR 37.40/tablet | 🔒 Pharma Pro |
| Danpro | Ciprofloxacin | 500 mg | Tablet | 10x5 | 038676 | PKR 1,869.86 | PKR 37.40/tablet | 🔒 Pharma Pro |
| Danque-H | Hydroxychloroquine | 200 mg | Tablet | 50's | 106076 | PKR 749.15 | PKR 14.98/tablet | 🔒 Pharma Pro |
| Danque-H | Hydroxychloroquine | 200 mg | Tablet | 30's | 106076 | PKR 449.49 | PKR 14.98/tablet | 🔒 Pharma Pro |
| Dansart | Losartan | 50 mg | Tablet | 2 x 10's | 094118 | PKR 337.65 | PKR 16.88/tablet | 🔒 Pharma Pro |
| Dansart | Losartan | 25 mg | Tablet | 2 x 10's | 094119 | PKR 185.71 | PKR 9.29/tablet | 🔒 Pharma Pro |
| Dansetron | Ondansetron | 4 mg | Tablet | 1 x 10’s | 094232 | PKR 1,001.81 | PKR 100.18/tablet | 🔒 Pharma Pro |
| Dansetron | Ondansetron | 8 mg/4 mL | Injection | 4ml x 5's | 103290 | PKR 4,150.81 | PKR 207.54/mL | 🔒 Pharma Pro |
| Dansetron | Ondansetron | 8 mg/4 mL | Injection | 4ml x 1's | 103290 | PKR 830.16 | PKR 207.54/mL | 🔒 Pharma Pro |
| Dansetron | Ondansetron | 4 mg/2 mL | Injection | 5x2ml | 109463 | PKR 2,716.56 | PKR 271.66/mL | 🔒 Pharma Pro |
| Dansetron | Ondansetron | 4 mg/2 mL | Injection | 1X2ml | 109463 | PKR 543.88 | PKR 271.94/mL | 🔒 Pharma Pro |
| Dansone | Betamethasone | 0.1% | Cream | 50 g | 038719 | PKR 166.10 | PKR 3.32/g | 🔒 Pharma Pro |
| Dansone | Betamethasone | 0.1% | Cream | 30 g | 038719 | PKR 99.66 | PKR 3.32/g | 🔒 Pharma Pro |
| Dantone | Omeprazole | 20 mg | Tablet | 14’s | 056710 | PKR 279.58 | PKR 19.97/tablet | 🔒 Pharma Pro |
| Danzodan | Linezolid | 600 mg | Tablet | 12’s | 083671 | PKR 4,962.47 | PKR 413.54/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 250 mg | Tablet | 3 x 10's | 056713 | PKR 2,016.37 | PKR 67.21/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 250 mg | Tablet | 1 x 10’s | 056713 | PKR 671.37 | PKR 67.14/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 500 mg | Tablet | 3 x 10's | 056714 | PKR 3,343.29 | PKR 111.44/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 500 mg | Tablet | 1 x 10’s | 056714 | PKR 1,114.43 | PKR 111.44/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 1000 mg | Tablet | 30's | 094122 | PKR 4,275.31 | PKR 142.51/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 1000 mg | Tablet | 10's | 094122 | PKR 1,425.11 | PKR 142.51/tablet | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 500 mg/5 mL | Injection | 10ml x 10's | 099865 | PKR 5,019.32 | PKR 50.19/mL | 🔒 Pharma Pro |
| Devenda | Levetiracetam | 500 mg/5 mL | Injection | 10ml x 1's | 099865 | PKR 501.93 | PKR 50.19/mL | 🔒 Pharma Pro |
| Hummor | Quetiapine | 300 mg | Tablet | 10’s | 091926 | PKR 1,356.30 | PKR 135.63/tablet | 🔒 Pharma Pro |
| Hyclodox | Doxycycline | 100 mg | Capsule | 10 x 10's | 094130 | PKR 658.42 | PKR 6.58/capsule | 🔒 Pharma Pro |
| Legion | Erythromycin | 500 mg | Tablet | 10's | 106365 | PKR 86.57 | PKR 8.66/tablet | 🔒 Pharma Pro |
| Legion | Erythromycin | 250 mg | Tablet | 10's | 106366 | PKR 44.95 | PKR 4.50/tablet | No comparator |
| Letrodan | Letrozole | 2.5 mg | Tablet | 30's | 094236 | PKR 13,284.80 | PKR 442.83/tablet | 🔒 Pharma Pro |
| Letrodan | Letrozole | 2.5 mg | Tablet | 1's | 094236 | PKR 442.83 | PKR 442.83/tablet | 🔒 Pharma Pro |
All 46 Danas Pharmaceuticals brands in Pakistan
- Aquadan Water for Injection · 5 mL injection
- Aquadan 10ml Water for Injection · 10 mL injection
- Arex Cetirizine · 10 mg tablet
- Artedan Artemether + Lumefantrine · 20 mg + 120 mg capsule
- Autist Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- B-Vir Entecavir · 0.5 mg tablet
- Burnhel Silver sulfadiazine · 1 % cream
- Carbil Carbimazole · 5 mg tablet
- Danabid Terbinafine · 1 % cream
- Danadex Dexamethasone · 4 mg injection
- Danidol Paracetamol · 500 mg tablet
- Danim Tranexamic acid · 500 mg injection
- Danpro Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Danque-H Hydroxychloroquine · 200 mg tablet
- Dansart Losartan · 25 mg tablet, 50 mg tablet
- Dansetron Ondansetron · 4 mg tablet, 4 mg/2 mL injection, 8 mg/4 mL injection
- Dansone Betamethasone · 0.1% cream
- Dantone Omeprazole · 20 mg tablet
- Danzodan Linezolid · 600 mg tablet
- Devenda Levetiracetam · 1000 mg tablet, 250 mg tablet, 500 mg tablet
- Hummor Quetiapine · 300 mg tablet
- Hyclodox Doxycycline · 100 mg capsule
- Legion Erythromycin · 250 mg tablet, 500 mg tablet
- Letrodan Letrozole · 2.5 mg tablet
- Levoden Levofloxacin · 250 mg tablet, 500 mg tablet
- Lidonex IM Lidocaine · 1 % injection
- Lornas Loratadine · 10 mg tablet
- Macroclar Clarithromycin · 250 mg tablet, 500 mg tablet
- Maladan Artemether · 80 mg injection
- Mayfanax Ibuprofen · 200 mg tablet, 400 mg tablet
- Medan Permethrin · 5% cream
- Metrodan Metronidazole · 200 mg tablet
- Micoden Miconazole · 2% w/w cream
- Moxitex Moxifloxacin · 400 mg tablet
- Nausvom Metoclopramide · 10 mg/2 mL injection
- Nozac Fluoxetine · 20 mg capsule
- Odanvir Oseltamivir · 75 mg capsule
- Olepra Olanzapine · 5 mg tablet
- Omenza Omeprazole · 20 mg capsule
- Paromax Paroxetine · 20 mg tablet
- Ribadan Ribavirin · 400 mg capsule
- Saveril Clozapine · 100 mg tablet, 25 mg tablet
- Soriodan Calcipotriol · 0.005% cream, 0.005% ointment
- Vegadon SR Paliperidone · 3 mg tablet, 6 mg tablet
- Voricon Voriconazole · 200 mg tablet
- Zee Azithromycin · 250 mg tablet, 250 mg capsule, 500 mg tablet
Danas Pharmaceuticals: common questions
How many products does Danas Pharmaceuticals have in Pakistan?
Danas Pharmaceuticals (Pvt) Ltd has 87 registered medicine presentations in Pakistan, sold under 46 brands and covering 44 generic medicines.
What are the main brands of Danas Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Danpro (Ciprofloxacin), Devenda (Levetiracetam), Dansetron (Ondansetron), Autist (Risperidone) and Vegadon SR (Paliperidone). This is not a sales ranking.
Which therapy areas does Danas Pharmaceuticals cover?
The most products are in Anti-infectives (36), CNS & mental health (22), Gastrointestinal & hepatology (10), Dermatology (4) and Pain & musculoskeletal (3).
Where can I see Danas Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.